inTRODUCTiOn
The voluntary withdrawal of artificial nutrition and hydration (ANH) in patients with severe disorders of consciousness (DoC, e.g., permanent vegetative states) constitutes a fundamental ethical issue extending beyond the boundaries of end-of-life decisions. The term "Vegetative State" was originally adopted to define "an organic body capable of growth and development but devoid of sensation and thought" (1) . In this frame, the traditional approach toward the suspension of ANH rested upon the view that patients in the Vegetative State had no residual capability to perceive pain (2, 3) . However, over the past few decades, an increasing number of studies (4) (5) (6) (7) (8) (9) (10) (11) have shown that strong claims about awareness in patients without behavioral responses to commands are unwarranted. Furthermore, there is again a high percentage of misdiagnoses in the assessment of these patients (12) (13) (14) .
Recently it was proposed the alternative name "unresponsive wakefulness syndrome" (VS/UWS) (15) , to define a condition characterized by the absence of response to commands or oriented voluntary movements in the presence of wakefulness. Neuroimaging studies demonstrated the existence of distinctive cerebral responses to noxious stimuli in conditions like VS/UWS and minimally conscious state (MCS) (16) (17) (18) . Yet, there is no univocal consensus about pain perception in patients with DoC. In a study by Demertzi and colleagues (19), 2,059 medical and paramedical professionals from 32 European countries were asked the following question: "can a patient in vegetative state feel pain?" Over 40% of those surveyed replied that these patients do not feel pain. The percentage was higher among medical doctors compared to paramedical caregivers (54 and 32%, respectively). This view was substantiated by the idea that, in the absence of consciousness, patients were not capable of experiencing and reporting a painful experience. However, recent advances in the pathophysiology of DoC, debunking the original tenet that patients with DoC do not perceive pain, suggest a reconsideration of the voluntary withdrawal of ANH (20) .
In this manuscript, we will briefly review the recent literature indicating that some patients with DoC reveal a form of residual awareness (21) and that they are capable of perceiving painful stimuli and exhibiting consistent responses to them. Furthermore, empirical evidence in the literature suggests that, when tested with the appropriate tools, these patients can exhibit consistent reactions to emotionally salient stimuli (5, 10, (22) (23) (24) (25) (26) (27) withdrawal of ANH should be carefully reconsidered on medical and ethical grounding.
pAin: DEFiniTiOn AnD nEUROAnATOMiCAL SUBSTRATES
Pain is defined as "… an unpleasant sensory and emotional experience arising from actual or potential tissue damage or described in terms of such damage…" (28) . Likewise, McCaffrey and Pasero (29) reported that "Pain is whatever the experiencing person says it is, existing whenever the experiencing person says it does. " Such subjectivity implies that pain may only be detected when a patient reports its manifestation. Therefore, the presence of consciousness would seem to constitute a fundamental prerequisite in the individual appraisal and experience of pain. Analogous considerations may be applied to the concept of suffering, defined as "the state of severe distress associated with events that threaten the intactness of the person" (30) . Furthermore, Turk and Wilson (31) proposed that "a person might experience significant pain-related suffering from a relatively low-level noxious stimulation if she or he believes the implications are ominous, interminable, and beyond their control" (31) . Within this framework, both pain and suffering seem to require the presence of consciousness. Several authors have shown that nociceptive stimuli elicit the activation of an extensive cortical network including somatosensory, insular, and cingulate areas, as well as frontal and parietal areas (32, 33) . In particular, nociception refers to the perception (conscious or not) of nociceptive stimuli (28) . The stimulation of nociceptors leads to the transmission of information via the spinothalamic tract to the thalamus and on to the cortex, with the midbrain and thalamus thought to be involved in the modulation of reflex response to nociceptive stimuli (34) . The cortical nociceptive network entails the secondary somatosensory (S2) cortex, with the posterior insula (lateral network), taking part in the sensory-discriminative features of the pain processing (35, 36) . However, the generation of a conscious experience of pain requires the activation of a more complex network. This network is often referred to as the "pain matrix. " The pain matrix entails two main subsystems (37) : the lateral neuronal network [secondary somatosensory (S2) cortex, lateral thalamus, and posterior insula], encoding sensory-discriminative information (38) , and the medial network [anterior cingulate cortex (ACC) and prefrontal cortex], encoding affective-cognitive information (39) . Also, the cerebellum plays a major role in processing aversive stimuli including pain (40) , contributing to the sensory-discriminative part of the pain processing network. Finally, motor-related areas (e.g., the striatum, cerebellum, and the supplementary motor area) are involved in pain perception and processing (41) . In addition to identifying the neuroanatomical structures involved in pain perception, these studies investigated the dynamics of activation (connectivity) of the pain matrix. Thus, results on cortical potential suggest that nociceptive input is first processed in the posterior insula, wherein it is coded in terms of intensity and anatomical location, and then conveyed to the anterior insula, where the emotional reaction to pain is elaborated (36, 42, 43) .
Furthermore, several authors demonstrated the existence in humans of multiple somatotopic representations of pain within the operculo-insular region. This mechanism may constitute a sensory-integration site that selectively targets emotional responses toward the specific injured body-site (44) . Finally, the pain matrix has been shown to vary with age and in response to the onset of pathologies. Some authors have suggested that structural deficits in regions involved in the modulation of pain, and in their connectivity, occur in chronic pain syndromes (45) .
pAin in pATiEnTS WiTH DOC
Pioneering studies attempting to quantify nociception in patients with DoC (46) systematically measured physiological variables like eye opening, breathing, heart rate, and blood pressure, and occasionally grimace-like or crying-like behavior (47) . However, notwithstanding their heuristic value, these signs are considered to be of subcortical origin, not necessarily reflecting a conscious perception of pain. Additional quantitative measurements of nociception in patients with DoC reported stereotyped responses (i.e., slow generalized flexion or extension of the upper and lower extremities), flexion withdrawal (i.e., withdrawal of the limb away from the point of the stimulation), and localization responses (i.e., the non-stimulated limb locates and makes contact with the stimulated body part at the point of stimulation), all of which were linked, respectively, to brainstem, subcortical, or cortical activity (nociceptive network or pain matrix) (32, 46, 48) .
Other studies investigated the extent to which the pain matrix responded to nociceptive stimuli in patients with DoC. For example, Boly et al. (16) observed that, in response to a noxious stimulus, patients in MCS showed "pain matrix" activation similar to that seen in normal controls (16) . Patients in VS/UWS also showed activation in the pain matrix, although this activation was much less prominent compared to controls (16) . An independent study performed by Markl et al. (49) observed the presence of significant activation in the sensory and affective components of the pain matrix in patients characterized by severe DoC (49) . In a study adopting laser-evoked potentials, the authors observed that painful stimuli may be processed even in patients with severe brain damage (50) . Functional magnetic resonance imaging (fMRI) has also been used to investigate brain mechanisms underlying the perception of pain in patients with DoC. Using this paradigm, Monti et al. (20) demonstrated that patients with a diagnosis of "unresponsive wakefulness syndrome" (UWS), evaluated at the bedside, exhibited measurable awareness. Therefore, the authors proposed that negative results in clinical trials or activation protocols do not necessarily imply the absence of cognitive processes in these patients (20) . Alternatively, it may be suggested that these patients were misdiagnosed due to the technical constraints of the bedside evaluation. Retrospective reports of patients surviving intensive care constitute an additional indication that patients with DoC may exhibit some form of appraisal of noxious stimuli. These individuals report vivid memories of pain, noise, sleep deprivation, thirst, hunger, heat, cold, fear, anxiety, isolation, physical restraint, lack of information, and absence of daylight (51) .
These empirical data corroborate the view that although patients with DoC may not be capable of exhibiting a detectable reaction to painful stimuli, they may nonetheless be capable of perceiving them (52) . These data do not demonstrate that all patients with severe disorders of consciousness perceive and/or exhibit pain; yet, they demonstrate that several patients, deemed incapable of experiencing pain, showed a consistent response to noxious stimuli. Regardless of whether this is due to misdiagnosis or technical limitations, these data contravene the tenet that all patients with severe disorders of consciousness do not experience pain.
COnCLUSiOn
For patients with severe pathologies (e.g., terminally ill), the dehydration and starvation may have benefits (patients could be intolerant of enteral feeding because of abdominal distension, vomiting, diarrhea, or fluid overload) and to refuse food and fluids and to have relief of distress through provision of medicine may be a right (53) . However, most patients in VS/UWS are unlikely to be intolerant of nutrition and hydration that are considered basic compassionate care because they promote physical and emotional well-being (54, 55) . Withdrawal of ANH has biologic consequences including distress and pain (56) .
Neurophysiological and fMRI studies are finding ways to assess awareness in VS/UWS patients (57, 58) . The identification of the "pain matrix" along with the design of experimental tools capable of detecting consistent patterns of brain activation in response to noxious stimuli allowed us to integrate the original definitions of pain, which rested largely upon subjective experiences with objective measurements.
These data, which bestow a heuristic advancement in the study of pain and consciousness, may also foster a reconsideration of the general attitude toward the management of pain in patients with DoC. Herein, our main interest is directed toward the withdrawal of ANH in these patients. With respect to the latter, Ogino and collaborators (59) demonstrated that dehydration, in control subjects, leads to increased brain activity in the anatomical structures involved in pain perception (ACC, insula, and thalamus). Thus, dehydration may per se constitute a source of pain in healthy subjects (60) . Furthermore, Perry et al. (60) reported that hydration status is an important modulator of the cerebrovascular response to cold pressor tests, which are commonly used to investigate cerebrovascular regulation. Therefore, dehydration may not only constitute a source of pain but also interfere with the ability to assess a nociceptive response in the patient. Ultimately, current experimental knowledge supports the notion that voluntary withdrawal of hydration may, under specific conditions, constitute a source of pain. Given the empirical data reported above, concerning pain perception in patients with DoC, it is tenable that the primary ethical, clinical, and deontological concerns shall relate to the suffering of the patient. Within this framework, the voluntary withdrawal of ANH may raise ethical concerns worth being addressed.
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